«We believe that we have developed a viable 21st - century microdosing technology to transform the 100 - year
old eyedropper paradigm with modern, high - precision smart technology,» said lead researcher, Tsontcho Ianchulev, M.D. MPH, professor of ophthalmology at the Icahn School of Medicine at Mount Sinai.